OHB SE (OHB)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 207.00 |
|---|---|
| 52-week range | 95.00 – 685.00 |
| Return, 1 month / 3 months | +17.3% / −13.7% |
| Return, 1 year / 3 years | +81.0% / +396.0% |
| Trend | Below its 200-day average |
| RSI (14) | 65 |
| Volatility (1 year) | 92.1% |
| Worst drawdown (1 year) | -74.5% |
| Average daily value traded | 7.11M EUR |
| Dividend yield | 0.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
OHB SE is a German space and technology company based in Bremen. It designs and builds satellites and space systems, including Earth observation and navigation spacecraft, and supplies equipment for human spaceflight. Its customers are mainly space agencies, institutional bodies and commercial satellite operators, and it also works in aerospace and industrial technology. The company carries out development and manufacturing work for European space programmes and for satellite-based services.
On this site OHB SE appears as a stock on the XETRA Stock Exchange (Germany), code OHB, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
OHB SE (OHB) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 207.00 on 23 October 2026.
Its price-based Market X-Ray is 30 out of 100 (a weak price profile), ranking 573 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 81.0% and over the last three months it fell 13.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 8 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -22.5% | ||
| From 52-week high | -66.3% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -13.8% | ||
| 6-month return | -29.7% | ||
| 12-month return, skipping the last month | 54.3% | ||
| Stability (higher is calmer) | 5 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 92.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -74.5% | ||
| Liquidity | 89 · Strong | Trades actively. | |
| Average daily value traded | 7.11M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 27 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.3% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +8.0% |
|---|---|
| 1 month | +17.3% |
| 3 months | −13.7% |
| 6 months | −29.7% |
| 1 year | +81.0% |
| 3 years | +396.0% |
| 5 years | +488.3% |
Signals
| 50-day / 200-day average | 186.60 / 267.19 |
|---|---|
| Golden / death cross (60 days) | Death, 39 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 12.37 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Jun 2026 | EUR 0.5903 |
| 13 Jun 2025 | EUR 0.5903 |
| 27 Jun 2024 | EUR 0.5903 |
| 26 May 2023 | EUR 0.5903 |
| 2 Jun 2022 | EUR 0.4722 |
| 27 May 2021 | EUR 0.4230 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.